Your browser doesn't support javascript.
loading
Stromal Protein-Mediated Immune Regulation in Digestive Cancers.
Gamradt, Pia; De La Fouchardière, Christelle; Hennino, Ana.
Affiliation
  • Gamradt P; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, F-69373 Lyon, France.
  • De La Fouchardière C; Cancer Research Center of Lyon, UMR INSERM 1052, CNRS 5286, F-69373 Lyon, France.
  • Hennino A; Department of Medical Oncology, Léon Bérard Center, F-69008 Lyon, France.
Cancers (Basel) ; 13(1)2021 Jan 05.
Article in En | MEDLINE | ID: mdl-33466303
The stromal tumor microenvironment (TME) consists of immune cells, vascular and neural structures, cancer-associated fibroblasts (CAFs), as well as extracellular matrix (ECM), and favors immune escape mechanisms promoting the initiation and progression of digestive cancers. Numerous ECM proteins released by stromal and tumor cells are crucial in providing physical rigidity to the TME, though they are also key regulators of the immune response against cancer cells by interacting directly with immune cells or engaging with immune regulatory molecules. Here, we discuss current knowledge of stromal proteins in digestive cancers including pancreatic cancer, colorectal cancer, and gastric cancer, focusing on their functions in inhibiting tumor immunity and enabling drug resistance. Moreover, we will discuss the implication of stromal proteins as therapeutic targets to unleash efficient immunotherapy-based treatments.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Cancers (Basel) Year: 2021 Type: Article Affiliation country: France